Antibiotic guidelines for community-acquired pneumonia: Are they effective and do physicians comply?

Maria Amodio-Groton, Mark J. Sinnett, Darren Culshaw, Ira Leviton

Research output: Contribution to journalArticle

Abstract

Antibiotic guidelines for common infectious diseases, including community-acquired pneumonia (CAP), were instituted at the Moses Division of Montefiore Medical Center, Bronx, NY. The effect of these guidelines on antibiotic prescribing by physicians and on clinical response in patients with CAP was measured. The study was conducted in 2 phases. In phase I, baseline data for 51 randomly selected inpatients were gathered. In phase II, physician compliance with guidelines was measured for 47 patients. Demographic information, Fine score, antibiotic therapy, time to initiation of antibiotic, blood and sputum culture results, time receiving intravenous antibiotics, mortality, and length of stay (LOS) were measured. Data from phases I and II were compared, and these data were compared with a national benchmark database of 3504 patients. Antibiotic guidelines were found to improve the initial selection of antibiotics for patients requiring hospitalization for CAP, decrease time to initiation of treatment, decrease duration of intravenous antibiotic therapy, and decrease duration of hospital LOS. Antibiotic use was affected by the severity of underlying pneumonia in the population.

Original languageEnglish (US)
Pages (from-to)40-46
Number of pages7
JournalDrug Benefit Trends
Volume15
Issue number8
StatePublished - Aug 1 2003

Fingerprint

Pneumonia
Guidelines
Anti-Bacterial Agents
Physicians
Length of Stay
Benchmarking
Sputum
Patient Selection
Communicable Diseases
Inpatients
Hospitalization
Therapeutics
Demography
Databases
Mortality
Population

Keywords

  • Antibiotic guidelines
  • Community-acquired pneumonia
  • Empiric treatment
  • Length of stay

ASJC Scopus subject areas

  • Pharmaceutical Science
  • Leadership and Management

Cite this

Antibiotic guidelines for community-acquired pneumonia : Are they effective and do physicians comply? / Amodio-Groton, Maria; Sinnett, Mark J.; Culshaw, Darren; Leviton, Ira.

In: Drug Benefit Trends, Vol. 15, No. 8, 01.08.2003, p. 40-46.

Research output: Contribution to journalArticle

Amodio-Groton, Maria ; Sinnett, Mark J. ; Culshaw, Darren ; Leviton, Ira. / Antibiotic guidelines for community-acquired pneumonia : Are they effective and do physicians comply?. In: Drug Benefit Trends. 2003 ; Vol. 15, No. 8. pp. 40-46.
@article{7ad27bc6d01a4957bad11f69dccd9ada,
title = "Antibiotic guidelines for community-acquired pneumonia: Are they effective and do physicians comply?",
abstract = "Antibiotic guidelines for common infectious diseases, including community-acquired pneumonia (CAP), were instituted at the Moses Division of Montefiore Medical Center, Bronx, NY. The effect of these guidelines on antibiotic prescribing by physicians and on clinical response in patients with CAP was measured. The study was conducted in 2 phases. In phase I, baseline data for 51 randomly selected inpatients were gathered. In phase II, physician compliance with guidelines was measured for 47 patients. Demographic information, Fine score, antibiotic therapy, time to initiation of antibiotic, blood and sputum culture results, time receiving intravenous antibiotics, mortality, and length of stay (LOS) were measured. Data from phases I and II were compared, and these data were compared with a national benchmark database of 3504 patients. Antibiotic guidelines were found to improve the initial selection of antibiotics for patients requiring hospitalization for CAP, decrease time to initiation of treatment, decrease duration of intravenous antibiotic therapy, and decrease duration of hospital LOS. Antibiotic use was affected by the severity of underlying pneumonia in the population.",
keywords = "Antibiotic guidelines, Community-acquired pneumonia, Empiric treatment, Length of stay",
author = "Maria Amodio-Groton and Sinnett, {Mark J.} and Darren Culshaw and Ira Leviton",
year = "2003",
month = "8",
day = "1",
language = "English (US)",
volume = "15",
pages = "40--46",
journal = "Drug Benefit Trends",
issn = "1080-5826",
publisher = "Cliggott Publishing Co.",
number = "8",

}

TY - JOUR

T1 - Antibiotic guidelines for community-acquired pneumonia

T2 - Are they effective and do physicians comply?

AU - Amodio-Groton, Maria

AU - Sinnett, Mark J.

AU - Culshaw, Darren

AU - Leviton, Ira

PY - 2003/8/1

Y1 - 2003/8/1

N2 - Antibiotic guidelines for common infectious diseases, including community-acquired pneumonia (CAP), were instituted at the Moses Division of Montefiore Medical Center, Bronx, NY. The effect of these guidelines on antibiotic prescribing by physicians and on clinical response in patients with CAP was measured. The study was conducted in 2 phases. In phase I, baseline data for 51 randomly selected inpatients were gathered. In phase II, physician compliance with guidelines was measured for 47 patients. Demographic information, Fine score, antibiotic therapy, time to initiation of antibiotic, blood and sputum culture results, time receiving intravenous antibiotics, mortality, and length of stay (LOS) were measured. Data from phases I and II were compared, and these data were compared with a national benchmark database of 3504 patients. Antibiotic guidelines were found to improve the initial selection of antibiotics for patients requiring hospitalization for CAP, decrease time to initiation of treatment, decrease duration of intravenous antibiotic therapy, and decrease duration of hospital LOS. Antibiotic use was affected by the severity of underlying pneumonia in the population.

AB - Antibiotic guidelines for common infectious diseases, including community-acquired pneumonia (CAP), were instituted at the Moses Division of Montefiore Medical Center, Bronx, NY. The effect of these guidelines on antibiotic prescribing by physicians and on clinical response in patients with CAP was measured. The study was conducted in 2 phases. In phase I, baseline data for 51 randomly selected inpatients were gathered. In phase II, physician compliance with guidelines was measured for 47 patients. Demographic information, Fine score, antibiotic therapy, time to initiation of antibiotic, blood and sputum culture results, time receiving intravenous antibiotics, mortality, and length of stay (LOS) were measured. Data from phases I and II were compared, and these data were compared with a national benchmark database of 3504 patients. Antibiotic guidelines were found to improve the initial selection of antibiotics for patients requiring hospitalization for CAP, decrease time to initiation of treatment, decrease duration of intravenous antibiotic therapy, and decrease duration of hospital LOS. Antibiotic use was affected by the severity of underlying pneumonia in the population.

KW - Antibiotic guidelines

KW - Community-acquired pneumonia

KW - Empiric treatment

KW - Length of stay

UR - http://www.scopus.com/inward/record.url?scp=0041762040&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0041762040&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0041762040

VL - 15

SP - 40

EP - 46

JO - Drug Benefit Trends

JF - Drug Benefit Trends

SN - 1080-5826

IS - 8

ER -